Figure 1 | Scientific Reports

Figure 1

From: Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma

Figure 1

Identify the biomarker through MALDI imaging mass spectrometry (MALDI IMS). (A) Overview of the strategy used for identification of the biomarkers of HNSCC. (B) Profiling of stage I, II, III and IV of HNSCC proteomes from MALDI IMS by the ClinProTools analysis. (C) Peaks found in Normal (OMF and NHOK) and cancer cells (TW1.5 and CAL27). (D) The left panel represented the histomorphology of clinical HNSCC samples subject to MALDI IMS analysis after H&E stain. The right panel showed the intensity distribution of 4968.1 m/z, which was stronger in advanced stages. Red arrow: the intensity of T > the intensity of N.

Back to article page